APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $19,531,000 | +48.0% | 309,031 | +0.5% | 0.02% | +40.0% |
| Q1 2021 | $13,198,000 | -27.7% | 307,575 | -3.6% | 0.02% | -31.8% |
| Q4 2020 | $18,256,000 | +368.0% | 319,154 | +146.8% | 0.02% | +340.0% |
| Q3 2020 | $3,901,000 | -87.8% | 129,319 | -86.8% | 0.01% | -88.4% |
| Q2 2020 | $31,998,000 | +8.2% | 979,716 | -11.3% | 0.04% | -12.2% |
| Q1 2020 | $29,586,000 | -30.7% | 1,104,349 | -20.8% | 0.05% | -16.9% |
| Q4 2019 | $42,693,000 | +61.5% | 1,394,285 | +27.1% | 0.06% | +47.5% |
| Q3 2019 | $26,431,000 | – | 1,097,202 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |